Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_assertion type Assertion NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_head.
- NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_assertion wasGeneratedBy ECO_0000203 NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_provenance.
- NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_assertion wasDerivedFrom befree-20140225 NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_provenance.
- NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_assertion SIO_000772 22740248 NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_provenance.
- NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_assertion evidence source_evidence_literature NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_provenance.
- NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_assertion description "[We found that bp -532 to -521 on the VEGF promoter is a putative binding site for Smads, and that the binding activity of Smad3 to VEGF promoter was constitutively increased in SSc fibroblasts as well as in normal fibroblasts treated with exogenous TGF-β1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706900.RAkjl7-hCjk7BIA6RQjNFMYwGd0t1yEAX9YFcFc2tXzVI130_provenance.